词条 | Society for Immunotherapy of Cancer |
释义 |
|name = Society for Immunotherapy of Cancer (SITC) |image = |formation = 1984 |type = Non-Profit Medical Society |headquarters = Milwaukee, WI |location =Milwaukee, Wis. |membership = |language = English |leader_title = Executive Director |leader_name = Tara Withington |key_people =Vice President Patrick Hwu, MD, University of Texas MD Anderson Cancer Center Secretary/Treasurer Kim A. Margolin, MD, City of Hope Immediate Past President Lisa H. Butterfield, PhD, Parker Institute for Cancer Immunotherapy |num_staff = |budget = |website = {{URL|http://www.sitcancer.org/}} |leader_title2=President|leader_name2=Mario Sznol, MD Yale School of Medicine}} The Society for Immunotherapy of Cancer (SITC), previously known as The International Society for Biological Therapy of Cancer (iSBTc) is a professional society of influential scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. Currently, SITC has more than 2,400 members, representing 22 medical specialties from 42 countries around the world, who are engaged in the research and treatment of cancer. Through emphasis on high-caliber scientific meetings, dedication to education and outreach activities, focus on initiatives of major importance to the field, and commitment to collaborations with like-minded organizations and patient advocacy groups, SITC brings together all aspects of the cancer immunology and immunotherapy community in an effort to make cancer immunotherapy one of the four standards of care and the word “cure” a reality for cancer patients living with this disease. The goals of SITC are directed towards the rapid dissemination of information in these areas to expedite the safe transfer of both basic and applied research to the clinical setting. Core Values
Goals
Annual Meeting & Pre-Conference ProgramsThe Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs brings together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world on cancer immunotherapy. As the largest conference solely focused on cancer immunotherapy, the Annual Meeting & Pre-Conference Programs provides more than 5,000 international leaders from academia, regulatory and government agencies, as well as industry representatives with a multidisciplinary educational and interactive environment focused on improving outcomes for all cancer patients.[2] ActivitiesSITC continues to increase the number of programs it offers [https://www.sitcancer.org/events/calendar] each year. The purpose of these programs – which include the Annual Meeting & Pre-Conference Programs, Advances in Cancer Immunotherapy™ educational series, and an array of collaborative education programs – is to bring together leaders to discuss the latest developments in cancer immunotherapy and biological therapy, and to focus on and educate the clinical and translational aspects of biologic approaches to cancer treatment.[3] MembershipSITC's membership consists of leaders in the field of cancer immunotherapy and up-and-coming scientists. This group includes research scientists, physician scientists, clinicians, patients, patient advocates, government representatives and industry leaders. In 2018, SITC grew to more than 2,400 members, representing 22 medical specialties and 42 countries around the world and are engaged in research and treatment of cancer.[4]PublicationsThe Journal for ImmunoTherapy of Cancer (JITC) is the official journal of the Society for Immunotherapy of Cancer (SITC). It is an open access, online journal created by the Society for the many stakeholders in the tumor immunology and cancer immunotherapy community. JITC is an outlet and targeted publication platform dedicated to advancing the science of tumor immunology and cancer immunotherapy.[5] References1. ^{{cite web|url=http://www.sitcancer.org/aboutsitc/mission|title=Core Values|last=|first=|date=|website=|work=About SITC|publisher=|archive-url=|archive-date=|dead-url=|access-date=|accessdate=24 August 2016}} {{DEFAULTSORT:Society for Immunotherapy of Cancer (SITC)}}2. ^{{Cite web|url=http://www.sitcancer.org/education/annualmeeting|title=SITC Annual Meeting & Pre-Conference Programs - Society for Immunotherapy of Cancer (SITC)|last=(SITC)|first=Society for Immunotherapy of Cancer|website=www.sitcancer.org|language=en|access-date=2017-10-13}} 3. ^{{cite web|title=Meetings|url=http://www.sitcancer.org/sitc-meetings|work=SITC Meetings|accessdate=18 March 2013}} 4. ^{{cite web|title=General Society|url=http://www.sitcancer.org/about-sitc/general-society|work=General Society|accessdate=18 March 2013}} 5. ^{{cite web|url=http://www.sitcancer.org/research/jitc|title=JITC|last=|first=|date=|work=About the Journal|archive-url=|archive-date=|dead-url=|accessdate=18 March 2013}} 4 : Cancer organizations based in the United States|Medical associations based in the United States|Medical and health organizations based in Wisconsin|Immunology organizations |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。